Detailed explanation of the correct way to take avatrombopag/sucoxin

Avatrombopag is a new oral thrombopoietic drug, and its correct use in the treatment of immune thrombocytopenia (ITP) has a decisive impact on the therapeutic effect. When using this drug, patients should not only clarify the mechanism of action and expected effects of the drug, but also pay attention to the method of taking the drug, timing, and precautions before and after taking the drug to ensure that the entire course of treatment is completed safely and standardizedly.

First, the recommended usage of Sucoxin is usually once daily orally, with individual dosage adjustments based on the patient's platelet count and underlying diseases. One of its biggest advantages is that it can be taken with meals and is not affected by cations such as calcium, iron, and magnesium in the diet, which is significantly different from some similar drugs. This feature greatly improves patients' medication compliance and reduces fluctuations in medication efficacy caused by food restrictions.

Before using Sucoxin, the doctor will determine the starting dose based on the patient's basic platelet level. In the preoperative management of chronic liver disease, it is generally recommended to initiate medication 5 to 10 days before surgery to ensure that the ideal platelet concentration is achieved on the day of surgery. In the long-term treatment of immune thrombocytopenia, the efficacy and side effects need to be regularly evaluated to decide whether to adjust the dose or discontinue the drug. This drug is not recommended for long-term and indefinite use, and the specific course of treatment should be evaluated and determined by a professional doctor.

During the medication process, patients should strictly follow the doctor's instructions and should not increase the dosage or stop the medication without authorization. If you miss a dose, you should take it as soon as possible on the same day. However, if it is close to the next dose time, you should skip it and do not take two doses at one time. During the medication period, platelet count and liver and kidney function need to be monitored regularly to detect adverse reactions or lack of efficacy in a timely manner. Especially for patients with liver damage or other hematological diseases, the drug metabolism rate may be different, so extra caution is required.

Reference materials:https://go.drugbank.com/drugs/DB11995